Ping An Healthcare and Technology Company Limited
PANHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.66 | 1.10 | 0.55 | -0.32 |
| FCF Yield | 0.97% | -1.86% | -4.18% | -5.93% |
| EV / EBITDA | 24.29 | -95.62 | -15.90 | -12.64 |
| Quality | ||||
| ROIC | -2.25% | -4.31% | -5.31% | -11.62% |
| Gross Margin | 31.68% | 32.28% | 26.93% | 23.27% |
| Cash Conversion Ratio | 1.06 | 0.85 | 1.33 | 0.91 |
| Growth | ||||
| Revenue 3-Year CAGR | -8.15% | -13.95% | -3.32% | 13.13% |
| Free Cash Flow Growth | 119.98% | 61.44% | 43.37% | -26.94% |
| Safety | ||||
| Net Debt / EBITDA | -10.34 | 10.80 | 3.36 | 1.62 |
| Interest Coverage | -26.20 | -83.54 | -65.36 | -151.75 |
| Efficiency | ||||
| Inventory Turnover | 35.15 | 15.94 | 18.19 | 14.14 |
| Cash Conversion Cycle | 23.15 | 25.80 | 54.50 | 33.55 |